XGN (STOCKS)
Exagen Inc. Common Stock
$2.970000
-0.060000 (-1.98%)
Prev close: $3.030000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- John Aballi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $71.56M
- Employees
- 209
- P/E (TTM)
- -3.23
- P/B (TTM)
- 3.98
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $66.58M |
| Benefits Costs and Expenses | $52.87M |
| Cost Of Revenue | $27.78M |
| Costs And Expenses | $52.87M |
| Gross Profit | $38.80M |
| Operating Expenses | $52.87M |
| Selling, General, and Administrative Expenses | $46.62M |
| Research and Development | $6.25M |
| Operating Income/Loss | -$14.07M |
| Income/Loss From Continuing Operations After Tax | -$19.95M |
| Income/Loss From Continuing Operations Before Tax | $13.71M |
| Income Tax Expense/Benefit | $51.00K |
| Income Tax Expense/Benefit, Current | $51.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$19.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$19.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.93 |
| Diluted Earnings Per Share | -$0.93 |
| Basic Average Shares | 21,558,245 |
| Diluted Average Shares | 21,558,245 |
| Assets | $58.02M |
| Current Assets | $48.89M |
| Noncurrent Assets | $9.13M |
| Liabilities | $40.57M |
| Current Liabilities | $14.16M |
| Accounts Payable | $4.15M |
| Other Current Liabilities | $10.01M |
| Noncurrent Liabilities | $26.41M |
| Long-term Debt | $22.91M |
| Other Non-current Liabilities | $3.51M |
| Equity | $17.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $17.45M |
| Liabilities And Equity | $58.02M |
| Net Cash Flow From Operating Activities | -$13.63M |
| Net Cash Flow From Operating Activities, Continuing | -$13.63M |
| Net Cash Flow From Investing Activities | -$626.00K |
| Net Cash Flow From Investing Activities, Continuing | -$626.00K |
| Net Cash Flow From Financing Activities | $24.44M |
| Net Cash Flow From Financing Activities, Continuing | $24.44M |
| Net Cash Flow | $10.18M |
| Net Cash Flow, Continuing | $10.18M |
| Comprehensive Income/Loss | -$19.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$19.95M |
| Other Comprehensive Income/Loss | $0.00 |